Filtered By:
Condition: Pain
Therapy: Vagus Nerve Stimulation Therapy
This page shows you your search results in order of relevance.
Order by Relevance | Date
Total 17 results found since Jan 2013.
Medtech approvals: FDA releases August 2015 PMAs
The FDA today released its list of the pre-market approvals it granted for medical devices in August 2015:
Summary of PMA Originals & Supplements Approved
Originals: 2
Supplements: 70
Summary of PMA Originals Under Review
Total Under Review: 57
Total Active: 28
Total On Hold: 29
Summary of PMA Supplements Under Review
Total Under Review: 569
Total Active: 422
Total On Hold: 147
Summary of All PMA Submissions
Originals: 5
Supplements: 90
Summary of PMA Supplement PMA Approval/Denial Decision Times
Number of Approvals: 70
Number of Denials: 0
Average Days Fr Receipt to Decision (Total Time): 229.0
FDA Time: 130...
Source: Mass Device - October 23, 2015 Category: Medical Equipment Authors: Brad Perriello Tags: Food & Drug Administration (FDA) Pre-Market Approval (PMA) Regulatory/Compliance Source Type: news
Transcutaneous auricular vagus nerve stimulators: a review of past, present and future devices
This article reviewed the history and classification of taVNS devices.EXPERT OPINION: The correlation between the effectiveness and stimulation parameters from taVNS devices still remains unclear. There is a lack of standard or harmonization among different taVNS devices. Strategies, including further comparative research and establishment of standard, have been recommended in this article to promote the future development of taVNS devices.PMID:34937487 | DOI:10.1080/17434440.2022.2020095
Source: Expert Review of Medical Devices - December 23, 2021 Category: Medical Devices Authors: Lei Wang Yu Wang Yifei Wang Fang Wang Jinling Zhang Shaoyuan Li Mozheng Wu Liang Li Peijing Rong Source Type: research
Transcutaneous auricular vagus nerve stimulators: a review of past, present, and future devices
This article reviewed the history and classification of taVNS devices.EXPERT OPINION: The correlation between the effectiveness and stimulation parameters from taVNS devices still remains unclear. There is a lack of standard or harmonization among different taVNS devices. Strategies, including further comparative research and establishment of standard, have been recommended in this article to promote the future development of taVNS devices.PMID:34937487 | DOI:10.1080/17434440.2022.2020095
Source: Expert Review of Medical Devices - December 23, 2021 Category: Medical Devices Authors: Lei Wang Yu Wang Yifei Wang Fang Wang Jinling Zhang Shaoyuan Li Mozheng Wu Liang Li Peijing Rong Source Type: research
Transcutaneous vagus nerve stimulation - A brief introduction and overview
Auton Neurosci. 2022 Sep 27;243:103038. doi: 10.1016/j.autneu.2022.103038. Online ahead of print.ABSTRACTInvasive cervical vagus nerve stimulation (VNS) is approved for the treatment of epilepsies, depression, obesity, and for stroke-rehabilitation. The procedure requires surgery, has side-effects, is expensive and not readily available. Consequently, transcutaneous VNS (tVNS) has been developed 20 years ago as non-invasive, less expensive, and easily applicable alternative. Since the vagus nerve reaches the skin at the outer acoustic canal and ear, and reflex-responses such as the ear-cough-reflex or the auriculo-cardiac ...
Source: Autonomic Neuroscience - October 6, 2022 Category: Neuroscience Authors: Max J Hilz Source Type: research
